Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Mannequinon Jul 25, 2023 12:26pm
77 Views
Post# 35556065

RE:RE:RE:Me think that

RE:RE:RE:Me think that

The resignation should have been bundled into the previous news release. And it could have easily been done that way. They are insanely bad at figuring out how to keep things calm.


PWIB123 wrote: Hillarious response!  It's easy to turn on the champions when things aren't working out, but it's shameful and irresponsible.  The company certainly isn't helping us out, but I don't blame SPCEO1 for communicating his ideas and thoughts around why this was/is a good investment.  The story isn't over yet either, so he may still have his day to look like a genius.  Certainly not fun right now.  

Here's something you can blame on the company.  The way the announcement of the board member resignation was completed.  I just can't seem to figure out why they would assume that would be received well by the broader market, especially the day after a reverse split was communicated. I doubt most people know it was requested by certain investors to shrink the board and they waited long enough that the results of the annual meeting may be lost in translation.  Reverse splits are bad news.  Leadership resignations can be bad news.  To announce it the very next day with no explanation as to why made it look like he was at odds with the decision and in disagreement with the path forward.  And then to suggest that they would be looking at growing the board again left it open for interpretation.  

 

<< Previous
Bullboard Posts
Next >>